Author:
Friesenbichler Joerg,Maurer-Ertl Werner,Bergovec Marko,Holzer Lukas A.,Ogris Kathrin,Leitner Lukas,Leithner Andreas
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Friesenbichler, J. et al. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX(R). Clin Orthop Relat Res 472, 976–982, doi: 10.1007/s11999-013-3305-z (2014).
2. Van Hoff, C. et al. Effectiveness of ultraporous beta-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors. Am J Orthop 41, 20–23 (2012).
3. Kurz, L. T., Garfin, S. R. & Booth, R. E. Jr. Harvesting autogenous iliac bone grafts. A review of complications and techniques. Spine. 14, 1324–1331, doi: 10.1097/00007632-198912000-00009 (1989).
4. Evaniew, N. et al. Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors. Orthopedics. 36, 216–222, doi: 10.3928/01477447-20130122-25 (2013).
5. Kelly, C. M. & Wilkins, R. M. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute. Orthopedics. 27, 131–135 (2004).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献